GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Days Payable

Invictus MD Strategies (Invictus MD Strategies) Days Payable : 538.96 (As of Oct. 2019)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Days Payable?

Invictus MD Strategies's average Accounts Payable for the three months ended in Oct. 2019 was $2.65 Mil. Invictus MD Strategies's Cost of Goods Sold for the three months ended in Oct. 2019 was $0.45 Mil. Hence, Invictus MD Strategies's Days Payable for the three months ended in Oct. 2019 was 538.96.

The historical rank and industry rank for Invictus MD Strategies's Days Payable or its related term are showing as below:

IVITF's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 86.3
* Ranked among companies with meaningful Days Payable only.

Invictus MD Strategies's Days Payable declined from Oct. 2018 (541.08) to Oct. 2019 (538.96). It may suggest that Invictus MD Strategies accelerated paying its suppliers.


Invictus MD Strategies Days Payable Historical Data

The historical data trend for Invictus MD Strategies's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Days Payable Chart

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
Days Payable
- 90.52 158.30 360.18 309.74

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 541.08 182.28 959.74 162.31 538.96

Competitive Comparison of Invictus MD Strategies's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's Days Payable distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's Days Payable falls into.



Invictus MD Strategies Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Invictus MD Strategies's Days Payable for the fiscal year that ended in Jan. 2019 is calculated as

Days Payable (A: Jan. 2019 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Jan. 2018 ) + Accounts Payable (A: Jan. 2019 )) / count ) / Cost of Goods Sold (A: Jan. 2019 )*Days in Period
=( (0.892 + 3.166) / 2 ) / 2.391*365
=2.029 / 2.391*365
=309.74

Invictus MD Strategies's Days Payable for the quarter that ended in Oct. 2019 is calculated as:

Days Payable (Q: Oct. 2019 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jul. 2019 ) + Accounts Payable (Q: Oct. 2019 )) / count ) / Cost of Goods Sold (Q: Oct. 2019 )*Days in Period
=( (2.517 + 2.787) / 2 ) / 0.449*365 / 4
=2.652 / 0.449*365 / 4
=538.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invictus MD Strategies Days Payable Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines

From GuruFocus

INVICTUS ANNOUNCES RESIGNATIONS

By Marketwired Marketwired 12-06-2019

INVICTUS ANNOUNCES CHANGE TO BOARD

By GlobeNewswire GlobeNewswire 12-13-2019

UPDATE ON ACREAGE PHARMS LTD.

By Marketwired Marketwired 06-12-2019

INVICTUS ANNOUNCES AB VENTURES INC. UPDATE

By Marketwired Marketwired 07-02-2019

INVICTUS ANNOUNCES $5,700,000 CONVERTIBLE DEBENTURE FINANCING

By Marketwired Marketwired 12-16-2019

INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.

By Marketwired Marketwired 10-17-2019

INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE

By Marketwired Marketwired 09-11-2019

ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

By Marketwired Marketwired 08-14-2019